Children's Bodies Process Cancer Chemical Differently, MIT Study Warns

Children's Bodies Process Cancer Chemical Differently, MIT Study Warns

A troubling discovery from MIT researchers suggests that children exposed to a contaminated water supply face dramatically higher cancer risk than adults drinking the same water, revealing a fundamental gap in how scientists test toxic chemicals.

The culprit is NDMA, a byproduct of industrial processes that has turned up in medications, contaminated drinking wells, and food. When young mice were exposed to low levels of NDMA in water, they developed far more DNA damage and cancer than adult mice given identical doses. The finding helps explain why children in Wilmington, Massachusetts, developed cancer at elevated rates after their water supply was contaminated by the Olin Chemical site in the 1990s.

"We really hope that groups that do safety testing will change their paradigm and start looking at young animals, so that we can catch potential carcinogens before people are exposed," said Bevin Engelward, an MIT professor of biological engineering who led the research.

The research, published in Nature Communications with postdoc Lindsay Volk as lead author, exposes a critical flaw in standard toxicology testing. Most cancer risk studies use adult animals, which can mask how dangerous chemicals are to children.

How Young Bodies Lose the Battle Against DNA Damage

When NDMA enters the body, a liver enzyme called CYP2E1 breaks it down into toxic byproducts that attack DNA, creating lesions called adducts. Both young and adult mice developed similar levels of this initial damage.

The divergence came in what happened next. Young mice suffered cascading double-stranded DNA breaks as their cells attempted repairs. These breaks triggered mutations that developed into liver tumors. Adult mice, by contrast, showed almost no double-strand breaks and far fewer mutations. Their livers remained largely cancer-free despite identical initial damage.

The reason lies in cellular metabolism. Juvenile livers are rapidly growing and dividing cells, which means DNA damage gets locked into permanent mutations during the repair process. Adult liver cells divide slowly, giving them time to fix damage correctly.

"The double-stranded breaks were exclusively observed in the young," Engelward said.

A small number of mice in the study also developed other cancers, including lung cancer and lymphoma, though the liver bore the brunt of the damage.

Even more concerning, when researchers stimulated cell growth in adult mice using thyroid hormone, they began accumulating mutations at rates matching young animals. This suggests that anything accelerating liver cell division, including viral infections, high-fat diets, or chronic alcohol use, could make adults more vulnerable to NDMA than standard testing would predict.

"We certainly don't want to say that adults are completely resistant to NDMA," Volk cautioned. "Everything impacts your susceptibility to a carcinogen, whether that's your genetics, your age, your diet, and so forth."

NDMA has surfaced in recent years in contaminated batches of the blood pressure medication valsartan and the stomach acid reducer ranitidine. It is also present in cigarette smoke and processed meats, though typically at much lower levels than industrial contamination.

The Wilmington case offers a real-world parallel to the lab findings. Between 1990 and 2000, 22 children in that town were diagnosed with cancer, a cluster linked to NDMA in drinking water. Contaminated wells were shut down in 2003, but the legacy of exposure persisted.

Author Jessica Williams: "The study dismantles the assumption that adult safety data automatically protects children, and it should reshape how regulators test chemicals before they reach the water supply."

Comments